Decline of antibody titres three months after two doses of BNT162b2 in non-immunocompromised adults
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.08.023
Abstract: Objective To assess the antibody response in non-immunocompromised adults after two doses of BNT162b2. Methods Prospective, single-centre observational study in non-immunocompromised adults > 18 years of age who received two doses of BNT162b2. The study contemplates… read more here.
Keywords: doses bnt162b2; three months; non immunocompromised; immunocompromised adults ... See more keywords